JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma

Overview of attention for article published in Science, June 2024

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

news: 15 news outlets
blogs: 2 blogs
twitter: 73 X users

facebook: 3 Facebook pages
wikipedia: 1 Wikipedia page
reddit: 2 Redditors

Readers on

mendeley: 119 Mendeley

So far, Altmetric has seen 3 public wall posts from 3 users.

Drgios world, 20 Jul 2024

#Immunotherapy News: Research co-funded by #NIAID found that a type of drug called a JAK inhibitor made a common form of cancer…

ALCASE Italia - Per la Lotta al Cancro del Polmone, 08 Jul 2024

Sembra che l'aggiunta di un farmaco antinfiammatorio all'immunoterapia con inibitori del checkpoint PD1 sia una nuova strategia…

National Institute of Allergy and Infectious Diseases (NIAID), 20 Jun 2024

#Immunotherapy News: Research co-funded by #NIAID found that a type of drug called a JAK inhibitor made a common form of cancer…

This page shows the most recent Facebook posts that mention this research output. Click here to find out how to access more activity.